Selective Degradation and Inhibition of SARS-CoV-2 3CLpro by MMP14 Reveals a Novel Strategy for COVID-19 Therapeutics is a research paper published in International Journal of Molecular Sciences (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 R01EY033758 (NEI)
National Institutes of Health
Grant: R21AI168744 (NIAID)
National Institutes of Health
Grant: P30 EY001792 (NEI)
Eversight
Grant: G1781
FWCI
0.00
Citation Percentile
0.3%
Fields of Study
MeSH Terms
Keywords